FR2439195A2 - Derives du naphtalene et leur application en therapeutique - Google Patents

Derives du naphtalene et leur application en therapeutique

Info

Publication number
FR2439195A2
FR2439195A2 FR7829413A FR7829413A FR2439195A2 FR 2439195 A2 FR2439195 A2 FR 2439195A2 FR 7829413 A FR7829413 A FR 7829413A FR 7829413 A FR7829413 A FR 7829413A FR 2439195 A2 FR2439195 A2 FR 2439195A2
Authority
FR
France
Prior art keywords
alkyl
antiinflammatories
antipyretics
analgesics
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7829413A
Other languages
English (en)
Other versions
FR2439195B2 (fr
Inventor
Thomas Andrew Purcell
Braham Shroot
Daniel Jean Marie Galtier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7829413A priority Critical patent/FR2439195A2/fr
Priority to DE7878400173T priority patent/DE2860314D1/de
Priority to EP78400173A priority patent/EP0002401B1/fr
Priority to DK519678A priority patent/DK519678A/da
Priority to US05/962,760 priority patent/US4243665A/en
Priority to ES475299A priority patent/ES475299A1/es
Priority to IL56021A priority patent/IL56021A/xx
Priority to NZ188982A priority patent/NZ188982A/xx
Priority to IT30063/78A priority patent/IT1101422B/it
Priority to NO783933A priority patent/NO783933L/no
Priority to AR274539A priority patent/AR225604A1/es
Priority to GR57721A priority patent/GR65321B/el
Priority to IE2313/78A priority patent/IE47677B1/en
Priority to AU41884/78A priority patent/AU517219B2/en
Priority to PT68821A priority patent/PT68821A/fr
Priority to FI783586A priority patent/FI783586A/fi
Priority to CA316,787A priority patent/CA1101858A/fr
Priority to MX10091278U priority patent/MX5009E/es
Priority to JP53145934A priority patent/JPS6039273B2/ja
Publication of FR2439195A2 publication Critical patent/FR2439195A2/fr
Application granted granted Critical
Publication of FR2439195B2 publication Critical patent/FR2439195B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DERIVES DU NAPHTALENE, REPONDANT A LA FORMULEIBIS: (CF DESSIN DANS BOPI) DANS LAQUELLE: R EST H OU CH; ET R REPRESENTE:-SOIT UN RADICAL-SOIT UN RADICAL-SOIT UN RADICAL APPLICATION EN THERAPEUTIQUE.
FR7829413A 1977-11-24 1978-10-16 Derives du naphtalene et leur application en therapeutique Granted FR2439195A2 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR7829413A FR2439195A2 (fr) 1978-10-16 1978-10-16 Derives du naphtalene et leur application en therapeutique
DE7878400173T DE2860314D1 (en) 1977-11-24 1978-11-10 Derivatives of naphthalene, process for their preparation and their therapeutic application
EP78400173A EP0002401B1 (fr) 1977-11-24 1978-11-10 Dérivés de naphtalène, leur préparation et leur application en thérapeutique
US05/962,760 US4243665A (en) 1977-11-24 1978-11-21 2-Heterocyclylalkyl-6-methoxy-naphthalenes
DK519678A DK519678A (da) 1977-11-24 1978-11-21 Fremgangsmaade til fremstilling af naphthalenderivater
IL56021A IL56021A (en) 1977-11-24 1978-11-22 2-heterocyclylalklyl-6-methoxy-naphathalenes,their preparation and pharmaceutical compositions containing them
NZ188982A NZ188982A (en) 1977-11-24 1978-11-22 2-heterocyclylalkyl-6-methoxynaphthalene derivatives and pharmaceutical compositions
IT30063/78A IT1101422B (it) 1977-11-24 1978-11-22 Derivati del naftalene
NO783933A NO783933L (no) 1977-11-24 1978-11-22 Fremgangsmaate for fremstilling av naftalenderivater
AR274539A AR225604A1 (es) 1977-11-24 1978-11-22 Procedimiento para obtener derivados de etil-2-metoxi-6-naftaleno y sus sales
ES475299A ES475299A1 (es) 1977-11-24 1978-11-22 Procedimiento para preparar derivados del naftaleno.
IE2313/78A IE47677B1 (en) 1977-11-24 1978-11-23 Naphthalene derivatives,their preparation and their therapeutic application
AU41884/78A AU517219B2 (en) 1977-11-24 1978-11-23 2-heterocyclyalkyl-6-methoxy-naphthalene
GR57721A GR65321B (en) 1977-11-24 1978-11-23 Method for the preparation of naphthalin derivatives
PT68821A PT68821A (fr) 1977-11-24 1978-11-23 Procede de preparation de derives de naphtalene
FI783586A FI783586A (fi) 1977-11-24 1978-11-23 Naftalenderivat
CA316,787A CA1101858A (fr) 1977-11-24 1978-11-23 Derives du naphtalene
MX10091278U MX5009E (es) 1977-11-24 1978-11-23 Procedimiento de preparacion de derivados de naftaleno
JP53145934A JPS6039273B2 (ja) 1977-11-24 1978-11-24 ナフタレン誘導体およびその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7829413A FR2439195A2 (fr) 1978-10-16 1978-10-16 Derives du naphtalene et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2439195A2 true FR2439195A2 (fr) 1980-05-16
FR2439195B2 FR2439195B2 (fr) 1981-02-27

Family

ID=9213774

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7829413A Granted FR2439195A2 (fr) 1977-11-24 1978-10-16 Derives du naphtalene et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2439195A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051469A1 (fr) * 2000-01-11 2001-07-19 Merck Patent Gmbh Piperidine et derives de la piperazine utilises comme antagonistes de recepteur 5-ht2a

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2119077A (en) * 1933-11-24 1938-05-31 Ostro Res Lab Inc Naphthalene derivatives containing a c h n group and process of producing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2119077A (en) * 1933-11-24 1938-05-31 Ostro Res Lab Inc Naphthalene derivatives containing a c h n group and process of producing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXRV/66 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051469A1 (fr) * 2000-01-11 2001-07-19 Merck Patent Gmbh Piperidine et derives de la piperazine utilises comme antagonistes de recepteur 5-ht2a

Also Published As

Publication number Publication date
FR2439195B2 (fr) 1981-02-27

Similar Documents

Publication Publication Date Title
TR199902303T2 (xx) Belirli halkal� tiyo ornat�lm�� a�ilaminoasit amit t�revleri.
FR2395256A1 (fr) Derives de l'acide phenylacetique leurs procedes de preparation et leurs applications en therapeutique
ATE70826T1 (de) Indolon-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ES8606395A1 (es) Un metodo de preparar peptidos farmaceuticamente activos
ATE1734T1 (de) Schmerzstillende tablette und verfahren zu deren herstellung.
TW355705B (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their medical use and pharmaceutical composition containing them
FR2439195A2 (fr) Derives du naphtalene et leur application en therapeutique
GB1514775A (en) Therapeutically active oxamic acid derivatives
FR2409994A1 (fr) Derives de naphtalene et leur application en therapeutique
ATE13523T1 (de) 11-deoxoglycyrrhetinsaeurehydrogenmaleinat, verfahren zu dessen herstellung und seine verwendung als medikament.
DK7286D0 (da) Octahydroindoliziner
GB1460348A (en) Quinazoline derivativesa
ATE280159T1 (de) Aromatische carbonsäureester, ihre herstellung und verwendung als heilmittel
GB1448547A (en) Derivative of phenylacetic acid
ATE167399T1 (de) Verwendung von sulfasalazin und/oder dessen aktiven metaboliten zur herstellung eines arzneimittels zur behandlung von venöser insuffizienz und venösen ulcera
ATE170400T1 (de) Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen
ATE40687T1 (de) Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
YU46319B (sh) Postupak za dobijanje 1-/3-merkapto-/2s/-metilpropionil/-pirolidin-/2s/-karboksilne kiseline
ES2020145A6 (es) Procedimiento de obtencion de esteres del acido 2-(2,6-diclorofenil)amino) fenilacetoxiacetico.
ES438537A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1-(2', 4', 6',-trihidroxifenil)-propandiona-(1, 2) sustitui-dos en la posicion 3.
ES475299A1 (es) Procedimiento para preparar derivados del naftaleno.
DE3461464D1 (en) Derivatives of d-2-(6-methoxy-2-naphthyl)-propionic acid having therapeutical activity, process for their preparation and pharmaceutical compositions containing them
ES418563A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil)- delta7 - desoxi-normorfinas y -norcodeinas.
IT1217589B (it) Agente antiinfiammatorio per la terapia dell'ipertrofia prostatica,sua preparazione e relative composizioni farmaceutiche
FR2415101A1 (fr) Nouveaux derives de la phenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments desdits produits